GlassScriptPhysician profile
Benjamin A Nahass
NPI 1245774314
$312.36
in general payments reported to CMS, 2019-2025
7 companies · $121 in 2025
The $121 reported for 2025 was more than what 78% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.32 · 2022: $14.32 · 2023: $57.31 · 2024: $108 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $111.53 | 2021-2025 | Bridion |
| Mindray Ds USA, INC. | $80.34 | 2022-2025 | A7 Anesthesia System, Na Electrode,Indirect,International, Patient Monitor |
| Becton, Dickinson and Company | $41.59 | 2025 | Hemosphere |
| Masimo Corporation | $23.43 | 2025 | Sedline |
| Boston Scientific Corporation | $20.62 | 2024 | Ams 700 |
| Solventum Corporation | $20.16 | 2024 | Bair Paws, Bair Hugger |
| Octapharma USA, INC. | $14.69 | 2025 | Fibryga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Nahass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.